Clinical trial
Multicenter, Prospective, Randomized, Controlled Open Study Albumin 20% Versus Saline
NCT00327704 is registered in ClinicalTrials.gov with Laboratoire français de Fractionnement et de Biotechnologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Prospective, Randomized, Controlled Open Study Albumin 20% Versus Saline
- Lead sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- January 31, 2011
- Enrollment
- 794 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock